期刊文献+

艾儒棣教授“圣愈方”联合中药调周法治疗黄褐斑的临床疗效观察

Clinical Observation on the Treatment of Chloasma by Professor Ai Ruyi's"Sheng Yu Fang"Combined with Chinese Herbal Medicine
下载PDF
导出
摘要 目的观察艾儒棣教授“圣愈方”联合中药调周法治疗黄褐斑的临床疗效。方法选取陕西中医药大学附属医院收治的120例黄褐斑患者,随机分为治疗组和对照组,每组60例。两组均采用圣愈方结合七白液外敷,治疗组在此基础上加用中药调周法,3个疗程后观察治疗效果。结果治疗组和对照组的总有效率分别是90.0%和71.7%,两组比较差异有统计学意义(P<0.05),治疗组治疗效果明显优于对照组。两组治疗期间均无明显不良反应发生。结论圣愈方联合中药调周法治疗黄褐斑是一种安全有效的方法。 Objective To observe the clinical efficacy of Professor Ai Ruyi's"Shengyufang"combined with traditional Chinese medicine to regulate chloasma.Methods A total of 120 patients with chloasma admitted to the Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine were randomly divided into the treatment group and the control group,with 60 cases in each group.The two groups were treated with Shengyufang combined with Qibai liquid.The treatment group was added with Chinese medicine to adjust the weekly method,and the therapeutic effect was observed after 3 courses.Results The total effective rate of the treatment group and the control group were 90.0%and 71.7%,respectively.The difference between the two groups was statistically significant(P<0.05).The treatment effect of the treatment group was significantly better than that of the control group.No significant adverse reactions occurred during the treatment period.Conclusion Shengyufang combined with traditional Chinese medicine to regulate chloasma is a safe and effective method.
作者 梁俊芳 纪春艳 LIANG Junfang;JI Chunyan(Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine,Xianyang 712000,China)
出处 《大医生》 2019年第6期14-15,共2页 Doctor
关键词 黄褐斑 圣愈方 中药调周法 chloasma shengyufang traditional chinese medicine
  • 相关文献

参考文献5

二级参考文献74

  • 1Njoo MD,Das PK,Bos JD,et al.Association of the Kobner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris.Arch Dermatol,1999,135(4):407-413.
  • 2Hamzavi I,Jain H,McLean D,et al.Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool:the Vitiligo Area Scoring Index.Arch Dermatol,2004,140(6):677-683.
  • 3Salim A, Rengifo-Parclo M, Vincent S, et al. Melasma//Williams H, Bigby M, Diepgen T, et al. Evidence-based dermatology. London : BMJ Books ,2003:553-567.
  • 4Piamphongsant T. Treatment of melasma: a review with personal experience. Int J Dermatol, 1998,37:897-903.
  • 5Palumbo A, d' Ischia M, Misuraca G, et al. Mechanism of inhibition of melanogenesis by hydroquinone. Biochim Biophys Acta, 1991,1073:85-90.
  • 6Haddad AL,Matos LF,Brunstein F,et al. A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma. Int J Dermatol,2003,42 : 153-156.
  • 7Romero C, Aberdam E, Larnier C, et al. Retinoic acid as modulator of UVB-induced melanocyte differentiation. Involvement of the melanogenic enzymes expression. J Cell Sci, 1994, 107 : 1095-1103.
  • 8Kimbrough-Green CK, Griffiths CE, Finkel LJ, et al. Topical retinoic acid (tretinoin) for melasma in black patients. A vehiclecontrolled clinical trial. Arch Dermatol, 1994,130:727-733.
  • 9Leenutaphong V, Nettakul A, Rattanasuwon P. Topical isotretinoin for melasma in Thai patients: a vehicle-controlled clinical trial. J Med Assoc Thai, 1999,82:868-875.
  • 10Shroot B. Pharmacodynamics and pharmacokinetics of topical adapalene. J Am Acad Dermatol, 1998,39( 2 Pt 3 ) :S17-24.

共引文献521

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部